| Pharmaceutical manufacturers GMP |
20 |
29 |
46 |
29 |
21 |
| Preclinical / non-clinical studies GLP |
9 |
7 |
7 |
4 |
2 |
| Clinical trials on medicinal products GCP |
6 |
5 |
12 |
13 |
7 |
| Pharmacovigilance GVP |
4 |
1 |
3 |
5 |
2 |
| Blood services |
3 |
8 |
4 |
5 |
6 |
| Hospital pharmacies and pharmaceutical centres |
15 |
21 |
22 |
22 |
14 |
| Pharmacies and subsidiary pharmacies |
44 |
56 |
57 |
75 |
24 |
| Pharmaceutical wholesalers |
31 |
15 |
28 |
30 |
25 |
| Tissue services providers |
29 |
25 |
25 |
24 |
23 |
| Organ donation and transplantation services |
5 |
2 |
6 |
6 |
1 |
| National ATMP manufacturing licence |
2 |
1 |
2 |
1 |
0 |
| Separate inspection of mandatory reserve supplies |
0 |
0 |
0 |
0 |
0 |
| Separate inspections under the Narcotics Act |
0 |
2 |
4 |
3 |
1 |
| Biobanks |
- |
- |
- |
- |
3 |
| GMO inspections |
- |
- |
- |
- |
5 |
| Total |
168 |
172 |
216 |
217 |
134 |
| Of which remote inspections |
- |
- |
- |
- |
43 |
| hybrid inspections |
- |
- |
- |
- |
15 |
| written / documentary inspections |
- |
- |
- |
- |
16 |
| Total |
- |
- |
- |
- |
74 |